(134 days)
IMTEC Sendax / MDI (Mini Dental Implant System) & Nobel Biocare / IPI (Immediate Provisional Implant System)
Not Found
No
The summary describes a system of dental implants and surgical tools, with no mention of AI or ML capabilities.
Yes
The device is described as providing "temporary support for provisional prosthetic device during the healing phase," indicating a therapeutic purpose for the patient.
No
Explanation: The device, Intermezzo TM Implant Systems, is described as providing temporary support for provisional prosthetic devices during the healing phase of permanent endosseous dental implants. Its components are used for implantation and surgical procedures, not for identifying or assessing a medical condition.
No
The device description clearly outlines physical components like implant fixtures, caps, and surgical instruments, indicating it is a hardware-based medical device system.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is for "temporary support for provisional prosthetic device during the healing phase of permanent endosseous dental implants." This describes a surgical implant used within the body, not a test performed on samples taken from the body to diagnose or monitor a condition.
- Device Description: The description details an "integrated system of endosseous dental implants" including "Implant Fixtures," "Protective Cap," and "Surgery Tray." These are all components used in a surgical procedure.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), reagents, or any other elements typically associated with in vitro diagnostics.
Therefore, the Intermezzo TM Implant System is a medical device used for surgical implantation, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Intermezzo TM Implant Systems are intended to load immediately in partially or fully edentulous mandibles and maxillae to serve as temporary support for provisional prosthetic device during the healing phase of permanent endosseous dental implants.
Product codes (comma separated list FDA assigned to the subject device)
DZE
Device Description
Intermezzo ™ Implant System is an integrated system of endosseous dental implants which designed to support prosthetic devices for partially or fully edentulous patients. Intermezzo ™ Implant System consists of Intermezzo ™ Implant Fixtures, Intermezzo Cap, and Implant System Surgery Tray. Implant Fixture Systems consist of one-stage, root-form dental implants, associated with protective cap, which provide the clinician to maintain the patients' gingival contour. The system also includes surgical and restorative instrumentation: lance drills, twist drills, unification drills, and handpiece drivers and hand drivers to provide the clinician to choose only those components required for each clinical situation. The devices covered by this submission are Intermezzo ™ Implant Fixtures, Intermezzo Protective Cap, and Intermezzo Implant System Surgery Tray.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
mandibles and maxillae
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Laboratory testing was conducted to determine device functionality and conformance to design input requirements.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
IMTEC Sendax / MDI (Mini Dental Implant System) & Nobel Biocare / IPI (Immediate Provisional Implant System)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.
0
10. 510(K) SUMMARY
Koslois
Mega'Gen Co., Ltd. 114-8, Eupchun-Ri, Jain-Myun, Gyeongsan, Gyeongbuk South Korea Phone : 82-53-857-5770 Fax
510(K) Summary
510(K) SUMMARY AND CERTIFICATION
This summary of 510(K) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR & 807.93
| 10-1. Submitter | Mega'Gen Co., Ltd. |
|---|---|
| 114-8, Eupchun-Ri, Jain-Myun, | |
| Gyeongsan, Gyeongbuk | |
| South Korea | |
| Phone : 82-53-857-5770, Fax : 82-53-857-5432 | |
| 10-2. US Agent / | |
| Contact Person | Dae Kyu Chang |
| 13340 E. Firestone Blvd. Suites J | |
| Santa Fe Springs, CA 90670 | |
| Phone : 562-404-8466, Fax : 562-404-2757 | |
| 10-3. Date Prepared | April 14, 2005 |
| 10-4. Device Name | INTERMEZZOTM IMPLANT SYSTEMS |
| IntermezzoTM Fixtures, IntermezzoTM Protective Cap, and | |
| IntermezzoTM Surgery Tray | |
| 10-5. Classification Name | Endosseous Dental Implant System |
| 10-6. Device Classification | Class II |
| Dental Devices panel | |
| 21 CFR § 872.3640 | |
| Regulation Number: 872.3640 | |
| 10-7. Predicate Devices | IMTEC Sendax / MDI (Mini Dental Implant System) & |
| Nobel Biocare / IPI (Immediate Provisional Implant System) | |
| 10-8. Performance | Laboratory testing was conducted to determine device |
| functionality and conformance to design input requirements. |
1
10-9. Device Description
Intermezzo ™ Implant System is an integrated system of endosseous dental implants which designed to support prosthetic devices for partially or fully edentulous patients. Intermezzo ™ Implant System consists of Intermezzo ™ Implant Fixtures, Intermezzo Cap, and Implant System Surgery Tray. Implant Fixture Systems consist of one-stage, root-form dental implants, associated with protective cap, which provide the clinician to maintain the patients' gingival contour. The system also includes surgical and restorative instrumentation: lance drills, twist drills, unification drills, and handpiece drivers and hand drivers to provide the clinician to choose only those components required for each clinical situation. The devices covered by this submission are Intermezzo ™ Implant Fixtures, Intermezzo Protective Cap, and Intermezzo Implant System Surgery Tray.
10-10. Packing / Labeling / Product Information
In a clean room that is Class 10,000 or less, put the product into a capsule, and then put the capsule in a pet container, which is 45mm by 75mm, then sealed the pet container with PERFECSEAL CR27 1073B Coated Tyvek®. Intermezzo ™ Implant Systems (Intermezzo ™ Implant Fixtures, Intermezzo Protective Cap, and Intermezzo Implant System Surgery Tray) will be packaged.
10-11. Intended Use
Intermezzo ™ Implant Systems is threaded one-piece implants designed for orthodontic one-stage surgical procedures in upper and lower jaw to provide a means of prosthetic attachment to restore a patient's chewing function. Intermezzo ™ Implant System consists of single-stage, root-form dental implants. The system is designed to provide immediate provisional implant to provide temporary support for prosthetic devices during the healing phase of permanent root form implants. Depends on a patient's quality of bone condition, Intermezzo ™ Fixtures are to be removed within six to ten weeks after the surgery. The system is intended for immediate placement in partially or fully edentulous mandibles and maxillae, in support of single or multiple-unit restorations including; cement retained, screw retained, or overdenture restorations.
2
10-12. Substantial Equivalence Comparison
Intermezzo ™ Implant Systems (Intermezzo ™ Implant Fixtures, Intermezzo ™ Protective Cap, and Intermezzo ™ Surgery Tools) and predicate implant systems share a substantially equivalent intended use. IMTEC Sendax / MDI (Mini Dental Implant System), Nobel Biocare / IPI (Immediate Provisional Implant System) and Intermezzo ™ Implant Systems (Intermezzo ™ Implant Fixtures, Intermezzo ™ Protective Cap, and Intermezzo ™ Surgery Tools) are similar in fundamental scientific technology in that they are all threaded, root form implants constructed of titanium with sandblasted surfaces. The subject and predicate devices are similar in size and materials. All three systems offer associated accessories and instruments. When compared with the predicate devices, no new questions of safety or effectiveness have been raised for the Intermezzo ™ Implant system.
10-13. Conclusion
The data submitted in this 510(K) Notification is to legally sale the following devices in U.S. market:
- Intermezzo Fixtures (Sizes: 1.6mm, 2.0mm, 2.5mm, 3.1mm) .
- . Intermezzo Protective Cap
- Surgical Tools Drill (Lance Drill, Twist Drill, and Unification Drill) . - Driver (Handpiece Connector, and Hand Driver)
The Intermezzo ™ Implant Systems (Intermezzo ™ Implant Fixtures, Intermezzo ™ Protective Cap, and Intermezzo ™ Surgery Tools) are substantially equivalent to the products such as IMTEC Sendax / MDI (Mini Dental Implant System) and Nobel Biocare / IPI (Immediate Provisional Implant System).
3
Image /page/3/Picture/1 description: The image shows the seal of the Department of Health and Human Services, USA. The seal features a circular border with the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" arranged around the perimeter. Inside the circle is a stylized emblem consisting of three abstract, wave-like shapes stacked vertically.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP - 2 2005
MegaGen Company Limited C/O Mr. Dae Kyu Chang KoDent, Incorporated 13340 East Firestone Boulevard, Suites J Santa Fe Springs, California 90670
Re: K051018
Trade/Device Name: Intermezzo Implant Systems Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: II Product Code: DZE Dated: July 29, 2005 Received: August 1, 2005
Dear Mr. Chang:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Mr. Chang
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice and incents as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Seattle Y.M.C.A.
Chíu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known): K051018
Device Name: INTERMEZZO ™ IMPLANT SYSTEMS
Indication For Use:
The Intermezzo TM Implant Systems are intended to load immediately in partially or fully edentulous mandibles and maxillae to serve as temporary support for provisional prosthetic device during the healing phase of permanent endosseous dental implants.
Prescription Use______________________________________________________________________________________________________________________________________________________________ × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Susan Vurrr'
(Division Sian-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices
510(k) Number: K051018